Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The evidence base is preclinical for IGF-1 LR3 specifically, with adjacent human data from native rhIGF-1 (mecasermin/Increlex)
and the third was squatting, using a flat container
This complete 2026 guide walks through the mechanisms, the key studies, and the practical research distinctions that matter most including how this copper peptide compares to next-generation peptides like Epithalon and MOTS-C
Sobos existing peptide offerings in a strategic way based on science and real-world results
US$ 29.95
US$ 29.36
US$ 27.55
US$ 21.29
US$ 21.14
